Koninklijke Philips NV (PHIA):企業の財務・戦略的SWOT分析

◆英語タイトル:Koninklijke Philips NV (PHIA) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDTC4785FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:85
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:Technology and Communications
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥53,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Koninklijke Philips NV (PHIA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Koninklijke Philips NV (Philips) is a diversified technology company that develops and manufactures medical systems and consumer electronics products. The company offers products and solutions in the areas of diagnostic imaging, enterprise diagnostic informatics, image-guided therapy, ultrasound, monitoring and analytics, sleep and respiratory care, population health management, connected care informatics and therapeutic care. It offers mother and child care, personal care and oral healthcare products, including power toothbrushes, brush heads, baby bottles, sterilizers, shavers, groomers, trimmers, skin care, hair care and hair removal products. It also provides kitchen and home appliances, such as juicers, blenders, Airfryer, food processors, vacuum cleaners, air purifiers, irons, steam generators, coffee appliances and accessories. The company has business presence across North America, Europe and Asia-Pacific. Philips is headquartered in Amsterdam, the Netherlands.

Koninklijke Philips NV Key Recent Developments

Mar 11,2021: Philips, American College of Cardiology and MedAxiom collaborate to shape the future of cardiovascular care delivery
Mar 10,2021: Philips, openDoctor partner to offer integrated patient engagement platform
Mar 08,2021: Philips and the Dutch development bank FMO combine forces to accelerate universal health coverage in Africa
Mar 03,2021: Benefits of Philips Ambient experience
Mar 03,2021: Philips and Disney join forces to improve the healthcare experience of children

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Koninklijke Philips NV – Key Facts
Koninklijke Philips NV – Key Employees
Koninklijke Philips NV – Key Employee Biographies
Koninklijke Philips NV – Major Products and Services
Koninklijke Philips NV – History
Koninklijke Philips NV – Company Statement
Koninklijke Philips NV – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Koninklijke Philips NV – Business Description
Business Segment: Connected Care
Overview
Performance
Business Segment: Diagnostics & Treatment
Overview
Performance
Business Segment: Others
Overview
Performance
Business Segment: Personal Health
Overview
Performance
Geographical Segment: China
Target Markets
Performance
Geographical Segment: France
Target Markets
Performance
Geographical Segment: Germany
Target Markets
Performance
Geographical Segment: Japan
Target Markets
Performance
Geographical Segment: Netherlands
Target Markets
Performance
Geographical Segment: Other Countries
Performance
Geographical Segment: The UK
Target Markets
Performance
Geographical Segment: The US
Target Markets
Geographical Segment: United States
Performance
R&D Overview
Koninklijke Philips NV – Corporate Strategy
Koninklijke Philips NV – SWOT Analysis
SWOT Analysis – Overview
Koninklijke Philips NV – Strengths
Koninklijke Philips NV – Weaknesses
Koninklijke Philips NV – Opportunities
Koninklijke Philips NV – Threats
Koninklijke Philips NV – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Koninklijke Philips NV, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 11, 2021: Philips, American College of Cardiology and MedAxiom collaborate to shape the future of cardiovascular care delivery
Mar 10, 2021: Philips, openDoctor partner to offer integrated patient engagement platform
Mar 08, 2021: Philips and the Dutch development bank FMO combine forces to accelerate universal health coverage in Africa
Mar 03, 2021: Benefits of Philips Ambient experience
Mar 03, 2021: Philips and Disney join forces to improve the healthcare experience of children
Mar 03, 2021: Survey cites enhanced patient experience and anxiety reduction as top benefits of Philips Ambient Experience
Mar 02, 2021: Philips spotlights new integrated informatics and system solutions to drive workflow optimization and advance precision diagnosis at ECR 2021
Mar 02, 2021: Shez Partovi to succeed Jeroen Tas as Philips’ Chief Innovation & Strategy Officer
Mar 02, 2021: Philips partners with DiA Imaging Analysis to enhance ultrasound with AI-based image quantification
Feb 23, 2021: Philips provides update on composition of its Supervisory Board and proposes reappointment of Marnix van Ginneken as member of its Board of Management
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Koninklijke Philips NV, Key Facts
Koninklijke Philips NV, Key Employees
Koninklijke Philips NV, Key Employee Biographies
Koninklijke Philips NV, Major Products and Services
Koninklijke Philips NV, History
Koninklijke Philips NV, Other Locations
Koninklijke Philips NV, Subsidiaries
Koninklijke Philips NV, Joint Venture
Koninklijke Philips NV, Key Competitors
Koninklijke Philips NV, Ratios based on current share price
Koninklijke Philips NV, Annual Ratios
Koninklijke Philips NV, Annual Ratios (Cont...1)
Koninklijke Philips NV, Annual Ratios (Cont...2)
Koninklijke Philips NV, Interim Ratios
Koninklijke Philips NV, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Koninklijke Philips NV (PHIA):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Azul SA (AZUL):企業の財務・戦略的SWOT分析
    Azul SA (AZUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • University Health Network-製薬・医療分野:企業M&A・提携分析
    Summary University Health Network (UHN) is a health care institution that provides patient care, research and educational services, and patient support services. It offers health care services such as palliative care, pharmacy and telehealth. UHN also provides specialized program services, accessibi …
  • Sinclair Broadcast Group, Inc.:企業のM&A・事業提携・投資動向
    Sinclair Broadcast Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sinclair Broadcast Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Applied Industrial Technologies Inc (AIT):企業の財務・戦略的SWOT分析
    Applied Industrial Technologies Inc (AIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Orly International, Inc.:企業の戦略・SWOT・財務情報
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • LuLu Group International:企業の戦略・SWOT・財務情報
    LuLu Group International - Strategy, SWOT and Corporate Finance Report Summary LuLu Group International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • VWR International LLC-医療機器分野:企業M&A・提携分析
    Summary VWR International LLC (VWR), a subsidiary of VWR Corp is a medical device company that offers healthcare equipment. The company’s products comprise adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshener dispensers, air regulation valves, aluminum foil, a …
  • Nayara Energy Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Nayara Energy Ltd (Nayara), formerly Essar Oil Ltd, a joint venture between Rosneft Oil Co, Trafigura Pte Ltd and UCP PE Investments Ltd, is a downstream company. It has presence in refining and marketing of oil refined products. The company operates a refinery at Vadinar in Gujarat, which i …
  • Barclays Bank of Kenya Ltd:企業の戦略・SWOT・財務分析
    Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report Summary Barclays Bank of Kenya Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Granit AD Skopje:企業の戦略・SWOT・財務情報
    Granit AD Skopje - Strategy, SWOT and Corporate Finance Report Summary Granit AD Skopje - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. ValiRx uses GeneICE technology, which enables silen …
  • Digirad Corp (DRAD)-医療機器分野:企業M&A・提携分析
    Summary Digirad Corp (Digirad) is a medical device company that offers mobile and on-site imaging solutions. The company offers camera products which include ergo, cardius x-ACT, cardius 2 XPO, corcam, quantumcam, and cardius 3 XPO. Its diagnostic services include nuclear cardiology, ultrasound, neu …
  • Sectra AB (SECT B):企業の財務・戦略的SWOT分析
    Sectra AB (SECT B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    MDU Resources Group Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary MDU Resources Group, Inc. (MDU) is an energy, and construction materials and services company. It mines aggregates and markets crushed stone, sand, gravel and related construction materials. The …
  • Chori Co Ltd (8014):企業の財務・戦略的SWOT分析
    Chori Co Ltd (8014) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • China Vanke Co., Ltd.:企業の戦略・SWOT・財務情報
    China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary China Vanke Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Viriom Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viriom Inc (Viriom) focuses on the development of antivirals for HIV treatment and prevention. The company’s lead pipeline product candidate Elpida, is a bioavailable prodrug, and VM-1500A, a non-nucleoside HIV reverse transcriptase inhibitor. Its partner portfolio includes Roche, ChemDiv, I …
  • Naia Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Naia Ltd (Naia) is a drug development company that funds and develops biotechnology companies addressing regional and global medical needs. The company develops and manufactures therapeutics for metabolic and rare diseases. It provides global drug development through funding, clinical develo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆